First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 166.82 USD -0.58%
Updated: Apr 25, 2024

Abbvie Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abbvie Inc
Total Liabilities & Equity Peer Comparison

Comparables:
GILD
AMGN
VRTX
REGN
SGEN

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Total Liabilities & Equity
$134.7B
CAGR 3-Years
-4%
CAGR 5-Years
18%
CAGR 10-Years
17%
Gilead Sciences Inc
NASDAQ:GILD
Total Liabilities & Equity
$62.1B
CAGR 3-Years
-3%
CAGR 5-Years
0%
CAGR 10-Years
11%
Amgen Inc
NASDAQ:AMGN
Total Liabilities & Equity
$97.2B
CAGR 3-Years
16%
CAGR 5-Years
8%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Liabilities & Equity
$22.7B
CAGR 3-Years
25%
CAGR 5-Years
29%
CAGR 10-Years
26%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Liabilities & Equity
$33.1B
CAGR 3-Years
24%
CAGR 5-Years
23%
CAGR 10-Years
27%
Seagen Inc
NASDAQ:SGEN
Total Liabilities & Equity
$3.6B
CAGR 3-Years
7%
CAGR 5-Years
18%
CAGR 10-Years
22%

See Also

What is Abbvie Inc's Total Liabilities & Equity?
Total Liabilities & Equity
134.7B USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Total Liabilities & Equity amounts to 134.7B USD.

What is Abbvie Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
17%

Over the last year, the Total Liabilities & Equity growth was -3%. The average annual Total Liabilities & Equity growth rates for Abbvie Inc have been -4% over the past three years , 18% over the past five years , and 17% over the past ten years .